Jane Street’s Century Therapeutics IPSC Stock Holding History

Jane Street’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.2K	Buy	+28,400	New	+$59.7K	﹤0.01%	10873

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jane Street's IPSC Position: Q1 2026 in Review

Jane Street sold out of Century Therapeutics (IPSC) in Q1 2026, closing a stake of 45,194 shares — an estimated $95K sold.

Jane Street first reported a position in IPSC in Q1 2023 and held it in 9 quarters. The position peaked at $248K in Q2 2025. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Jane Street reported no remaining Century Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 45,194 Century Therapeutics shares in Q1 2026, an estimated $95K.
Jane Street first reported a position in Century Therapeutics in Q1 2023 and held it in 9 quarters.
Jane Street's Century Therapeutics position peaked at $248K in Q2 2025.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.